Related Experiment Videos

Gentamicin treatment in peripheral vestibular disorders other than Ménière's disease

K Brantberg1, J Bergenius, A Tribukait

  • 1Department of Audiology, Karolinska Hospital, Stockholm, Sweden.

Insights

Intratympanic gentamicin injections effectively manage vertigo in various peripheral vestibular disorders beyond Ménière's disease. This treatment offers relief for conditions like vestibular dysfunction, sudden hearing loss sequelae, and benign paroxysmal positioning vertigo.

Area of Science:

  • Otolaryngology
  • Neurology
  • Vestibular System Disorders

Background:

  • Intratympanic gentamicin is a recognized treatment for Ménière's disease.
  • Its efficacy in other peripheral vestibular disorders is less established.

Observation:

  • This study presents five case reports detailing the use of intratympanic gentamicin.
  • The cases involve diverse peripheral vestibular conditions, including vestibular dysfunction in deaf ears, post-idiopathic sudden hearing loss vertigo, benign paroxysmal positioning vertigo, and vertigo associated with acoustic neuroma.

Findings:

  • Successful vertigo control was achieved in all five cases.
  • Gentamicin provided relief for vertigo attacks and sensations of linear acceleration in non-Ménière's conditions.
  • The treatment was effective even in complex cases, such as in elderly patients or those with acoustic neuroma.

Implications:

  • Intratympanic gentamicin may be a viable therapeutic option for a broader range of peripheral vestibular disorders.
  • This expands the potential applications of gentamicin beyond its traditional use in Ménière's disease.
  • Further research could validate these findings and establish treatment protocols for these conditions.

Related Concept Videos